PreppinPeppers › Facts › Lab article
Amycretin: Reference Overview and Reconstitution Notes
Machine-readable facts for this Lab article. The full page is https://www.preppinpeppers.com/blogs/the-lab/amycretin.
TL;DR
Amycretin (NN9487) is an early-stage single-molecule peptide designed to engage both the GLP-1 and amylin receptors. Research reference and handling notes.
Facts Index
| Fact ID | Category | Entity | Attribute | Value | Source |
|---|---|---|---|---|---|
| amycretin:title | identity | Amycretin: Reference Overview and Reconstitution Notes | title | Amycretin: Reference Overview and Reconstitution Notes | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:published | identity | Amycretin: Reference Overview and Reconstitution Notes | published | 2026-08-15 | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:author | identity | Amycretin: Reference Overview and Reconstitution Notes | author | Preppin' Peppers Editorial Team | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:topics | identity | Amycretin: Reference Overview and Reconstitution Notes | topics | Investigational, research | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:summary | content | Amycretin: Reference Overview and Reconstitution Notes | summary | Amycretin (NN9487) is an early-stage single-molecule peptide designed to engage both the GLP-1 and amylin receptors. Research reference and handling notes. | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-1 | content | Amycretin: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-2 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Amycretin | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-3 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Amycretin | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-4 | content | Amycretin: Reference Overview and Reconstitution Notes | section | What it is | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-5 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Research context and categorization | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-6 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Status | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-7 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Reconstitution notes (general) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-8 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Dilution and handling notes (compound-specific) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-9 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Handling and storage | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-10 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Related reading | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-11 | content | Amycretin: Reference Overview and Reconstitution Notes | section | Tools and supplies | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:section-13 | content | Amycretin: Reference Overview and Reconstitution Notes | section | What the research community gets wrong about Amycretin | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:product-gansulin-metal-peptide-pen | products | Amycretin: Reference Overview and Reconstitution Notes | references product | Gansulin Pen · Reusable Click-Dial, 3 ml (1-60 Units) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:product-gansulin-3ml-cartridge | products | Amycretin: Reference Overview and Reconstitution Notes | references product | Gansulin-Compatible 3 ml Glass Cartridge for Pens (10-Pack) | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:source-pubmed-ncbi-nlm-nih-gov | source | Amycretin: Reference Overview and Reconstitution Notes | cites | Gasiorek et al., Lancet 2025: Safety, tolerability, pharmacokinetics, and pharmacodynamics of the first-in-class GLP-1 and amylin receptor agonist, amycretin: a first-in-human, phase 1, double-blind, randomised, placebo-controlled trial - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:source-pubmed-ncbi-nlm-nih-gov-2 | source | Amycretin: Reference Overview and Reconstitution Notes | cites | Dahl et al., Lancet 2025: Amycretin, a novel, unimolecular GLP-1 and amylin receptor agonist administered subcutaneously: results from a phase 1b/2a randomised controlled study - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:source-pmc-ncbi-nlm-nih-gov | source | Amycretin: Reference Overview and Reconstitution Notes | cites | Kuhre et al., EBioMedicine 2025: The effect of amycretin, a unimolecular glucagon-like peptide-1 and amylin receptor agonist, on body weight and metabolic dysfunction in mice and rats - pmc.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:source-pubmed-ncbi-nlm-nih-gov-3 | source | Amycretin: Reference Overview and Reconstitution Notes | cites | Fu et al., Metabolism 2026: Amycretin in obesity: Mechanisms, clinical efficacy, and future perspectives - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:source-pubmed-ncbi-nlm-nih-gov-4 | source | Amycretin: Reference Overview and Reconstitution Notes | cites | Son et al., Endocr Rev 2026: Novel GLP-1-based Medications for Type 2 Diabetes and Obesity - pubmed.ncbi.nlm.nih.gov | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
| amycretin:source-www-uniprot-org | source | Amycretin: Reference Overview and Reconstitution Notes | cites | UniProtKB/Swiss-Prot P43220: Glucagon-like peptide 1 receptor (GLP1R, Homo sapiens), UniProt release 2026-03 - www.uniprot.org | Lab article (https://www.preppinpeppers.com/blogs/the-lab/amycretin) (evidence) |
FAQ
- What receptors does Amycretin target and how is it classified?
- Amycretin is a single-molecule agonist that simultaneously activates the GLP-1 receptor and the amylin receptor, placing it in the metabolic and weight-regulation research category.
- What is Amycretin's regulatory and competition status?
- No. As of mid-2026 it remains strictly investigational (through phase 2), not approved by any regulator, with no prescribing route and no compounding pathway. WADA prohibits it under S0 (Non-Approved Substances) and S2 (Peptide Hormones/Mimetics).
- How is a lyophilized Amycretin research vial reconstituted?
- Divide the vial's milligram content by the milliliters of bacteriostatic water added to get mg/mL (e.g., 10 mg ÷ 2 mL = 5 mg/mL). Add water slowly down the inner vial wall, then swirl gently until dissolved.